Does RUXOLITINIB Cause Type iii immune complex mediated reaction? 15 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Type iii immune complex mediated reaction have been filed in association with RUXOLITINIB (OPZELURA). This represents 0.0% of all adverse event reports for RUXOLITINIB.
15
Reports of Type iii immune complex mediated reaction with RUXOLITINIB
0.0%
of all RUXOLITINIB reports
15
Deaths
15
Hospitalizations
How Dangerous Is Type iii immune complex mediated reaction From RUXOLITINIB?
Of the 15 reports, 15 (100.0%) resulted in death, 15 (100.0%) required hospitalization.
Is Type iii immune complex mediated reaction Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUXOLITINIB. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
What Other Drugs Cause Type iii immune complex mediated reaction?
RITUXIMAB (25)
VANCOMYCIN (24)
HUMAN IMMUNOGLOBULIN G (23)
OXALIPLATIN (23)
METHOTREXATE (19)
MYCOPHENOLATE MOFETIL (18)
TACROLIMUS (18)
CYCLOPHOSPHAMIDE (17)
BORTEZOMIB (16)
CYCLOSPORINE (16)
Which RUXOLITINIB Alternatives Have Lower Type iii immune complex mediated reaction Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE